CVS Health Corporation $CVS Position Increased by Quantinno Capital Management LP

Quantinno Capital Management LP boosted its stake in shares of CVS Health Corporation (NYSE:CVS) by 49.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,393,802 shares of the pharmacy operator’s stock after purchasing an additional 461,114 shares during the quarter. Quantinno Capital Management LP’s holdings in CVS Health were worth $100,103,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CVS. Swiss RE Ltd. bought a new stake in CVS Health in the fourth quarter valued at $26,000. Sankala Group LLC bought a new position in shares of CVS Health during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares during the period. Mcguire Capital Advisors Inc. bought a new stake in CVS Health in the 4th quarter valued at about $28,000. Finally, Ares Financial Consulting LLC bought a new stake in CVS Health in the 4th quarter valued at about $29,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Larry Robbins sold 370,462 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90. Following the sale, the director directly owned 4,824,799 shares in the company, valued at approximately $450,877,466.55. The trade was a 7.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the sale, the executive vice president directly owned 10,133 shares of the company’s stock, valued at $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 3,441,551 shares of company stock valued at $323,703,977. Insiders own 0.85% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the stock. Weiss Ratings upgraded shares of CVS Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, July 20th. Bank of America lifted their price target on CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Wells Fargo & Company increased their price objective on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Argus raised their target price on CVS Health from $90.00 to $104.00 and gave the company a “buy” rating in a research report on Thursday, May 14th. Finally, Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, July 23rd. Twenty-one research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $105.67.

CVS Health Stock Down 0.6%

CVS stock opened at $107.05 on Tuesday. The firm’s 50-day moving average is $100.43 and its two-hundred day moving average is $86.35. The company has a market capitalization of $136.59 billion, a price-to-earnings ratio of 47.16, a price-to-earnings-growth ratio of 1.05 and a beta of 0.61. CVS Health Corporation has a 52 week low of $58.99 and a 52 week high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The business had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. During the same period last year, the firm posted $2.25 earnings per share. The business’s revenue was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, analysts forecast that CVS Health Corporation will post 7.46 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Thursday, July 23rd. CVS Health’s payout ratio is currently 117.18%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.